NAYA Biosciences Inc (NAYA) - Gross Profit Rate

NAYA (NAYA Bio) - company brandmark

NAYA Biosciences develops cutting-edge bispecific antibodies, protecting its innovations with FLEX-NK patents to prevent acquisition by pharma industry behemoths. The consolidated gross margin illustrates cost efficiency, while the 34.20 metric determines the status of the profitability parameter. Operations are deployed within safe haven US jurisdictions, maintaining humanitarian immunity. Currently, NAYA Biosciences relies on external financing and grants due to a lack of consistent operating revenue.

NAYA: NAYA Biosciences Inc. Gross Margin 07/04/2022 - 04/28/2025

Analytical breakdowns and data insights for company nayabiosciences.com (NAYA)

- market value and analyst target forecast:
- market capitalization indicators:
Fundamental valuation:NAYA, NAYA Biosciences Inc.
Signature product of NAYA Biosciences

NAYA Biosciences' development of innovative antibodies for cancer therapy defines the cost structure for creating targeted drugs. Gross margin measures the portion of revenue remaining after direct production costs, reflecting the efficiency of the technological platform's utilization. Extremes in the base gross margin signal shifts in operating profitability, allowing investors to timely identify the risk of capital freeze or growth potential.

Direct competitors

Gross Profit Margin BeiGene Ltd. (ONC)|Return on Gross Profit HALO|Gross Profitability RVMD|Return on Gross Profit AAPG (Ascentage)|Return on Gross Profit cgoncology.com CGON|UroGen Pharma - Return on Gross Profit|Gross Profit Rate BCAX|PSNL - Gross Profitability|Return on Sales by Gross Profit Erasca Oncology ERAS|delcath.com (DCTH) - Gross Profitability|Y-mAbs Therapeutics - Gross Profit Rate|AURA (Aura Biosciences Inc) - Gross Margin|Gross Profit Margin candeltx.com CADL|Gross Margin ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Gross Profit Rate|Gross Profitability Actuate Therapeutics, Inc. ACTU|citiusonc.com - Gross Profitability|TuHURA Biosciences Inc. - Gross Margin|TARA - Gross Margin|FATE (Fate Therapeutics) - Return on Gross Profit|Return on Gross Profit Aadi Bioscience, Inc.|Return on Gross Profit TCRX|Gross Profitability CSBR|Gross Margin XBIT|Return on Sales by Gross Profit CEL-SCI Corp.|Gross Profitability ostherapies.com OSTX|RADX: Gross Return on Sales|ARTV: Return on Gross Profit|ANL (Adlai Nortye) - Gross Return on Sales|Veru (VERU) - Gross Profitability|Return on Gross Profit Tempest Therapeutics Inc|Gross Profitability Xilio Therapeutics|Gross Return on Sales RENB (Renovaro Inc.)|Gross Profitability Mural Oncology PLC (MURA)|Gross Margin Kairos Pharma (KAPA)|Gross Profitability onkuretherapeutics.com OKUR|GDTC: Gross Return on Sales|CRIS: Return on Gross Profit|apollomicsinc.com (APLM) - Return on Gross Profit|THAR: Gross Margin|Return on Gross Profit Advanced Biomed Inc.|Return on Gross Profit GNPX|Gross Return on Sales CLDI (Calidi Biotherapeutics)|Gross Margin SBFM|Xenetic Biosciences, Inc. - Gross Return on Sales|Gross Profitability Salarius Pharmaceuticals SLRX|Gross Margin purple-biotech.com PPBT|AONC - Gross Profitability|BGNE: Gross Profitability|CKPT: Gross Margin|Elevation Oncology - Gross Profit Rate|ICAD (iCAD) - Gross Margin|IKNA: Gross Profit Rate|Gross Profitability Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Gross Profit Rate|Gross Profitability MorphoSys Corporation MOR|AAPGV - Return on Gross Profit